Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-08-04
2010-10-19
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S467000
Reexamination Certificate
active
07816393
ABSTRACT:
Novel isoindoline compounds are disclosed. Methods of treating, preventing and/or managing cancer, diseases and disorders associated with, or characterized by, undesired angiogenesis, and diseases and disorders mediated by PDE 4, using the compounds are also disclosed.
REFERENCES:
patent: 6326388 (2001-12-01), Man et al.
patent: 6380239 (2002-04-01), Muller et al.
patent: 7405237 (2008-07-01), Muller et al.
Byrn et al. Solid-State Chemistry of Drugs, 2d, Chapter 11 Hydrates and Solvates, 233-247, 1999.
Man Hon-Wah
Muller George W.
Anderson Rebecca L
Celgene Corporation
Nolan Jason M
LandOfFree
Isoindoline compounds and methods of their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoindoline compounds and methods of their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoindoline compounds and methods of their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4214774